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Abstract
Background: Cellular senescence is an irreversible cell cycle arrest that normal cells undergo in response to
progressive shortening of telomeres, changes in telomeric structure, oncogene activation or oxidative stress and
acts as an important tumour suppressor mechanism.
Results: To identify the downstream effectors of the p53-p21 and p16-pRB tumour suppressor pathways crucial for
mediating entry into senescence, we have carried out a loss-of-function RNA interference screen in conditionally
immortalised human fibroblasts that can be induced to rapidly undergo senescence, whereas in primary cultures
senescence is stochastic and occurs asynchronously. These cells are immortal but undergo a rapid irreversible arrest
upon activation of the p53-p21 and p16-pRB pathways that can be readily bypassed upon their inactivation. The
primary screen identified 112 known genes including p53 and another 29 shRNAmirs targetting as yet unidentified
loci. Comparison of these known targets with genes known to be up-regulated upon senescence in these cells, by
micro-array expression profiling, identified 4 common genes TMEM9B, ATXN10, LAYN and LTBP2/3. Direct silencing
of these common genes, using lentiviral shRNAmirs, bypassed senescence in the conditionally immortalised cells.
Conclusion: The senescence bypass screen identified TMEM9B, ATXN10, LAYN and LTBP2/3 as novel downstream
effectors of the p53-p21 and p16-pRB tumour suppressor pathways. Although none of them has previously been
linked to cellular senescence, TMEM9B has been suggested to be an upstream activator of NF-B signalling which
has been found to have a causal role in promoting senescence. Future studies will focus on determining on how
many of the other primary hits also have a casual role in senescence and what is the mechanism of action.
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Background
Normal somatic cells undergo a finite number of divi-
sions before entering a state of irreversible growth arrest
termed cellular senescence [1]. This is triggered in
response to a variety of intrinsic and extrinsic stimuli
including progressive telomere shortening or changes in
telomeric structure at the ends of chromosomes or
other forms of genotoxic stress such as oncogene activa-
tion, or DNA damage or oxidative stress, resulting in a
DNA damage response and growth arrest via activation
of the p53 tumour suppressor pathway [2,3]. Non-geno-
toxic stress induces senescence by a telomere indepen-
dent mechanism involving activation of the p16-pRB
pathway by up-regulation of p16
INK4a [3,4].
Cellular senescence acts as an important tumour sup-
pressor mechanism. Overcoming senescence and acquir-
ing a limitless replicative potential has been proposed to
be one of the key events required for malignant trans-
formation [5]. Senescence is thought to have evolved as
an example of antagonistic pleiotrophy, whereby its ben-
eficial traits in a reproductively active individual have
deleterious effects later inl i f e[ 6 , 7 ] .T h eu n d e r l y i n g
* Correspondence: p.jat@prion.ucl.ac.uk
1Department of Neurodegenerative Disease, UCL Institute of Neurology,
Queen Square, London WC1N 3BG, UK
Full list of author information is available at the end of the article
Rovillain et al. BMC Genomics 2011, 12:355
http://www.biomedcentral.com/1471-2164/12/355
© 2011 Rovillain et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.mechanisms that control cellular senescence, the signal
transduction pathways involved and how the diverse sig-
nals that result in senescence are all integrated, remain
poorly defined. Moreover the downstream effectors of
the p53-p21 and p16-pRB pathways that result in the
irreversible growth arrest and entry into senescence are
unknown.
The discovery of RNA interference as a mechanism to
silence gene expression has revolutionized studies on
mammalian gene expression and has permitted loss-of-
function genome-wide genetic screens, to identify genes
involved in a variety of cellular processes, to be per-
formed [8-12]. A number of shRNA libraries have been
developed for carrying out such genome-wide screens,
one of which is the pSM2 Retroviral shRNAmir library
[13] (Thermo Scientific Open Biosystems). This library
has several unique features that make it very versatile
and efficient for large-scale screens particularly the
human microRNA-30 (miR30) adapted design which
increases knockdown specificity and efficiency [14].
Here we present a RNA interference screen using the
human pSM2 retroviral shRNAmir library, carried out
in the conditionally immortal HMF3A human fibro-
blasts, to identify genes whose silencing bypasses senes-
cence arrest induced by activation of the p53-p21 and
p16-pRB pathways. The primary screen identified 112
known genes and another 29 shRNAmirs targetting as
yet unidentified loci. Comparison of the known targets
with genes known to be up-regulated upon senescence
by micro-array expression profiling, identified 4 com-
mon genes whose expression was reversed when senes-
cence was bypassed upon inactivation of the p53-p21
and p16-pRB pathways.
Results
To directly identify the downstream effectors of the
p53-p21 and p16-pRB pathways, we have utilized the
conditionally immortal HMF3A human fibroblasts that
were derived by immortalising adult human mammary
fibroblasts with the catalytic subunit of human telomer-
ase and a thermolabile U19tsA58 mutant of SV40 Large
T antigen [15]. These cells are immortal if grown at 34°
C but undergo a senescence arrest upon inactivation of
the thermolabile U19tsA58 T antigen resulting in the
activation of the p53-p21 and p16-pRB pathways [15].
They are stringently temperature sensitive but senes-
cence can be readily bypassed by inactivation of the
p53-p21 or the p16-pRB pathway [16]. To facilitate effi-
cient transduction of these cells by retroviral infection,
they were transduced with the full length murine eco-
tropic retroviral receptor and CL3
EcoR cells derived, that
most closely mirror the parental cells [16]. The tempera-
ture dependent senescent arrest of CL3
EcoR cells and its
bypass upon inactivation of p21
CIP1 by silencing or
sequestration of the RB family of proteins by HPV16 E7
are shown in Figure 1.
The pSM2 library version 1.3 comprising 15,148 con-
structs targetting 9,392 human cancer associated genes
was amplified and each 96 well plate used to prepare a
pool of plasmid DNA; each of the 100 pools contained
between 150 to 200 different shRNAmir constructs with
each gene being represented by 1 to 3 shRNAmirs. To
ensure that CL3
EcoR cells were sufficiently sensitive to
identify a single shRNAmir construct in a pool of 200
shRNAmir constructs, pRSp21F (a p21
CIP1 shRNA con-
struct) [17] was mixed in a ratio of 1:200 with pRSLa-
minA/C and used to assay bypass of senescence in
CL3
EcoR cells. The pRSp21F construct was used because
the pSM2 library version 1.3 did not contain any silen-
cing constructs for p21
CIP1. Silencing of LaminA/C did
not bypass senescence, very few growing colonies were
obtained (Figure 2a) whereas silencing of p21
CIP1 was
very efficient and produced essentially a confluent
monolayer of growing cells (Figure 2b). The 1:200
p21
CIP1/LaminA/C mix produced numerous distinct
Figure 1 Characteristics of CL3
EcoR cells. a:C L 3
EcoR cells are
immortal at 34°C but undergo a senescence arrest upon shift up
38°C. b: Senescence is bypassed upon silencing of p21
CIP1 using
pRSp21F or sequestration of RB family of proteins by HPV16 E7.
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Page 2 of 12densely growing colonies (Figure 2c) indicating that
CL3
EcoR cells and the procedure were sufficiently sensi-
tive to generate colonies in which senescence had been
overcome.
ShRNA interference screen
The formula: ln [1-0.95]/ln [1-1/(Library Size)] recom-
mended for genetic screens by the Nolan lab (http://
www.stanford.edu/group/nolan/screens/screens.html),
suggested that approximately 1000 independent infec-
tious events would be sufficient for a 99% confidence
that all shRNAs within a pool had been sampled. To
ensure that the screen would be saturating, virus suffi-
cient to yield 10,000 infectious events was utilised for
each pool (shown in Additional File 1). The screen was
performed in successive waves of 10 pools. To minimise
variation and background reversion, CL3
EcoR cells were
used at the same passage for every pool. Virus prepared
from pRSp21F and pRSLamin A/C was used as positive
and negative controls respectively to evaluate the level
of background and ensure that the complementation
assay worked for each round of the screen. Stably
transduced cells were trypsinised and reseeded. Three
weeks after reseeding, flasks were examined to identify
growing colonies; a representative colony is shown in
Figure 3. Each colony was examined microscopically to
ensure it comprised growing cells and the number of
Figure 2 Sensitivity of the screen. CL3
EcoR cells were infected with retroviruses prepared from pRSLamin A/C (a), pRSp21F (b), or a 1/200 mix
of pRSp21F/pRSLamin A/C (c). After puromycin selection, cells were reseeded at 8.5 × 10
4 per 15 cm plate or 0.5 × 10
4 per well in 6-well plates
and shifted to 38°C for 3 weeks.
Figure 3 ShRNA screen.C L 3
EcoR cells were transduced with
ecotropic retroviruses prepared from each of the 100 pools of
shRNAmirs, selected with puromycin, reseeded and shifted up to
38°C for 3 weeks. Densely growing colonies were considered to
have bypassed senescence and potentially contain candidate
shRNAmirs.
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ber of stably transduced cells, the number of flasks
reseeded and the number of colonies obtained for each
flask at 38°C are shown in Additional File 2. The flasks
which contained more densely growing/bigger colonies
(indicated in red in Additional File 2) were trypsinised,
replated and used for extracting genomic DNA when
confluent.
34 out of 100 pools yielded healthy growing colonies;
pools 13, 78 and 82 particularly gave a higher number
of colonies which were also larger. Pools 16, 18, 19, 21
and 80 also yielded colonies but they were smaller. For
each pool that contained growing colonies, 1 to 4 flasks
containing the highest number of growing colonies,
were reseeded for extracting genomic DNA and resulted
in a total of 81 sub-pools.
Identification of shRNAmirs
The shRNAmir proviral inserts were by amplified by
two rounds of nested PCR using pSM2 specific primers,
the amplified products TOPO cloned and plasmid DNA
extracted from at least six colonies sequenced to identify
all shRNAs present within each pool; for some pools,
DNA from many more colonies was sequenced. The
hair pin sequence was determined by searching for the
miR-30 context and the miR-30 loop that are common
to all inserts and frame the hair pin. The sequence of
the hair pin was used to identify the target gene by
searching the pSM2 data base or by BLASTN analysis of
the NCBI human genome data base (http://blast.ncbi.
nlm.nih.gov/Blast.cgi). Sequences that could not be
linked back to the list of hair pin sequences within the
Open Biosystems collection or were not 100% homolo-
gous to a gene within Genbank were not pursued and
are presented in Additional File 3.
The rescued shRNAmir hair pins identified 112
known genes and another 29 shRNAmirs targetting as
yet unidentified loci. For each pool, the number of times
that sequence was obtained, the corresponding insert
reference, gene name and the number of shRNAmir
constructs for that gene within the SM2 library are
shown in Table 1. The last column of the table indicates
if the recovered insert was a match to a hair pin present
in that particular pool ("match”) or if it was present
within another pool ("listed in pool X”). 14 hair pins
were isolated from incorrect pools. Some inserts were
detected several times in multiple pools. For example,
the hair pin v2HS_119967 (corresponding to
LOC155004) listed within pool 52 was also identified
from pool 3, 4, 5, 9, 12, 30, 59, 60, 64, 71, 72, 74, 77,
and 98 suggesting that there may have been some cross-
contamination of the library perhaps during replica plat-
ing. However, this was not a problem since the aim of
our screen was to identify shRNAmirs that are able to
bypass senescence and does not depend upon the iden-
tity of the pool. Since this insert was isolated from so
many pools, it could be that it is a strong positive or
that it was highly represented within the library and
likely to be a false positive.
Pool 13, 78 and 82 that produced more colonies and
colonies that were larger and healthier than others,
identified the following genes: Pool 13: DYNLRB1,
FARSLB, PPARGC1A, TAOK1, CEND1, ABL1,
LOC342404, TMEM168, SIRPG, IYD and SMCR7; Pool
78: PRRX1, SLC25A21, ARMCX2, LOC284804,
LOC349839, MRP63, TMEM63B, ZBTB1, KIA0286 and
EIF4A1; and Pool 82: EIF4A1, CCDC70, PRICKLE2,
P L P 1 ,S A M D 4 A ,R A S A 4 ,T P 5 3 ,A R N T L ,B C L 2 L 1 2 ,
ADNP2, DSG4, LOC345672, LOC349975, LOC349811
and ARHGAP20. Moreover, pool 82, one of the pools
that gave the best senescence bypass, contained the only
shRNAmir targetting p53, v2HS_93615 identified in the
screen, thereby internally validating it.
Overlap of the primary candidates of the shRNA screen
with microarray data for genes up-regulated upon
senescence in CL3
EcoR cells
To prioritise the candidates identified from the primary
screen for functional validation, they were compared to
genes up-regulated upon senescence and whose expres-
sion was reversed when senescence was abrogated upon
inactivation of the p53 and pRB pathways [[16]; micro-
array expression profiling data is available from Gene
Expression Omnibus database accession number
GSE24810]. This identified 4 common genes, ATXN10,
LAYN, LTBP2/3 and TMEM9B. The microarray expres-
sion profiling data presented in Table 2 showed that
they were all up-regulated upon senescence growth
arrest: ATXN10 by 1.3 fold (p-value 1 × 10
-3), LAYN by
2f o l d( p - v a l u e2×1 0
-4), LTBP2/3 by 2.5 (p-value 9 ×
10
-8), 1.7 (p-value 5 × 10
-9), 1.5 (p-value 8 × 10
-4)a n d
1.4 fold (p-value 5 × 10
-5) and TMEM9B by 1.4 (p-value
1×1 0
-7) and 1.3 fold (p-value 2 × 10
-4) respectively.
The data in Table 2 further show that up-regulation of
these candidates was reversed when senescence was
bypassed upon inactivation of the p53-p21 and p16-pRB
pathways by silencing p53 (pRS_p53) or p21
CIP1
(pRS_p21) or by sequestration of the RB family of pro-
teins by HPV16 E7 or by expression of the dominant
negative E2F-DB protein.
The identification of TMEM9B was particularly
remarkable because the microarray analysis has sug-
gested that senescence growth arrest in CL3
EcoR cells is
associated with activation of the NF-B signalling path-
way and TMEM9B has previously been shown to be
able to activate NF-B dependent reporter constructs
[18,19]. To determine if silencing of TMEM9B would
bypass senescence, 4 GIPZ lentiviral silencing constructs
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Pool Insert Gene name Gene symbol Freq Cons per Gene Library location
3 v2HS_63142 keratin associated protein 5-9 KRTAP5-9 3/9 1 match
v2HS_119967 LOC155004 LOC155004 4/9 2 pool 52
v2HS_56766 acyl-CoA synthetase medium-chain family member 3 ACSM3 1/9 2 match
v2HS_59294 glycoprotein hormone alpha 2 GPHA2 1/9 1 match
v2HS_53974 PRO0255 protein PRO0255 5/8 1 match
v2HS_63482 paired box gene 1 PAX1 2/8 1 match
4 v2HS_119967 LOC155004 LOC155004 2/10 2 pool 52
v2HS_66751 LOC344082 LOC344082 4/10 1 match
v2HS_70011 serum amyloid A-like 1 SAAL1 2/10 2 match
v2HS_98079 human solute carrier family 22 SLC22A3 1/10 2 pool 79
5 v2HS_108647 LOC349868 LOC349868 3/8 1 pool 79
v2HS_70473 polymerase (DNA directed), mu POLM 2/8
v2HS_71958 human olfactory receptor, family 5, subfamily P, member 3 OR5P3 3/8 1 match
v2HS_119967 LOC155004 LOC155004 7/12 2 pool 52
v2HS_66652 protein phosphatase 3, catalytic subunit, b isoform PPP3CB 1/12 1 match
v2HS_70473 polymerase (DNA directed), mu POLM 4/12
7 v2HS_112910 human cyclin-dependent kinase 8 CDK8 1/10 3 match
v2HS_98079 solute carrier family 22, member3 SLC22A3 1/10 2 pool 79
v2HS_97017 sterile alpha motif containing 4a SAMD4A 1/10
v2HS_69776 cytochrome P450, family 4, subfamily Z, polypeptide CYP4Z2P 1/10 2 match
2 pseudogene
9 v2HS_108647 LOC349868 LOC349868 1/8 1 pool 79
v2HS_119967 LOC155004 LOC155004 1/8 2 pool 52
v2HS_62506 family with sequence similarity 181, member B FAM181B 1/8 1 match
v2HS_55950 prostate stem cell antigen PSCA 2/13 1 match
v2HS_119967 LOC155004 LOC155004 3/13 2 pool 52
v2HS_70312 TRK-fused gene TFG 4/13 3 match
v2HS_71740 ataxin 10 ATXN10 1/13 1 match
v2HS_98079 solute carrier family 22, member 3 SLC22A3 1/13 2 pool 79
v2HS_65121 sorting nexin 12 SNX12 1/13 1 match
v2HS_64384 amyloid beta precursor protein binding family A member 2 APBA2 1/6 1 match
v2HS_97017 sterile alpha motif containing 4A SAMD4A 1/6
12 v2HS_119967 LOC155004 LOC155004 5/11 2 pool 52
v2HS_58950 signal-regulatory protein beta 2 SIRPB2 3/11 2 match
protein tyrosine phosphatase, non-receptor type 13 PTPN13 1/10
v2HS_119967 LOC155004 LOC155004 5/10 2 pool 52
13 v2HS_55731 phenylalanine-tRNA synthetase-like, beta subunit FARSLB 1/12 2 match
v2HS_59258 dynein, light chain, roadblock-type 1 DYNLRB1 3/12 1 match
v2HS_59891 TAO kinase 1 TAOK1 5/12 3 match
v2HS_162164 iodotyrosine deiodinase IYD 1/12
cell cycle exit and neuronal differentiation 1 CEND1 1/12
transmembrane protein 168 TMEM168 2/5
v2HS_68714 abl-interactor 1 ABL1 3/5 3 match
cell cycle exit and neuronal differentiation 1 CEND1 4/6
v2HS_58952 signal regulatory protein gamma SIRPG 1/6 2 pool 14
v2HS_59653 LOC342404 LOC342404 1/6 1 match
v2HS_55731 phenylalanyl-tRNA synthetase like, beta subunit FARSLB 1/15 2 match
v2HS_64320 Smith-Magenis syndrome chromosome region, candidate 7 SMCR7 1/15 1 match
v2HS_71174 peroxisome proliferator-activated receptor, gamma PPARGC1A 3/15 1 match
v2HS_71453 similar to IAP-associated factor VIAF1; phosducin-like 2/15 1 match
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16 v2HS_68478 CD28 antigen CD28 8/12 2 pool 13
v2HS_63107 dopamine beta hydoxylase DBH 2/12 1 match
v2HS_61750 LOC100129230 LOC100129230 7/13 3 match
LOC9142 LOC9142 2/13
V2HS_62831 membrane bound O-acyltransferase domain containing 1 MBOAT1 3/13 2 match
18 v2HS_63989 STAR-related lipid transfer (START) domain containing 6 STARD6 1/14 2 match
LOC730256 LOC730256 1/14
19 v2HS_58958 TMEM9 domain family, member B/C11orf15 TMEM9B 3/10 1 match
v2HS_57051 RNA binding motif, single stranded interacting protein 1 RBMS1 5/10 1 match
v2HS_106158 LOC345672 LOC345672 1/10 2 pool 82
v2HS_59560 chromosome 13 open reading frame 15 C13orf15 10/10 1 match
21 v2HS_55312 glucosamine-phosphate N-acetyltransferase 1 GNPNAT1 6/9 2 match
v2HS_68437 LOC157503 LOC157503 2/9 3 match
30 v2HS_119967 LOC155004 LOC155004 6/14 2 pool 52
v2HS_34338 protein phosphatase 4, regulatory subunit 2 PPP4R2 7/14 3 match
v2HS_119967 LOC155004 LOC155004 1/13 2 pool 52
v2HS_36467 solute carrier family 33 (acetyl-CoA transporter), member 1 SLC33A1 8/13 3 match
v2HS_46793 ubiquitin-like modifier activating enzyme 3 UBA3 1/13 1 match
32 v2HS_42104 citrate lyase beta like (CLYBL), transcript variant 1 CLYBL 5/7 1 match
LOC100129563 LOC 10012956 1/7
41 v2HS_48278 choline kinase-like CHKL 6/6 1 match
54 v2HS_112629 basic transcription factor 3, like 1 BTF3L1 1/5 1 match
v2HS_121153 LOC221399 LOC221399 2/5 1 match
v2HS_125538 LOC350103 LOC350103 1/5 1 match
v2HS_129527 LOC351851 LOC351851 6/6 1 match
v2HS_112629 basic transcription factor 3, like 1 BTF3L1 2/6 1 match
55 v2HS_117465 SH3 domain binding glutamic acid-rich protein like 2 SH3BGRL2 2/6 1 match
v2HS_119051 LOC90841 LOC90841 1/6 1 match
v2HS_116174 YTH domain containing 2 YTHDC2 1/7 2 pool 58
v2HS_119120 hypothetical protein FLJ20032 FLJ20032 6/7 2 match
56 V2HS_120429 six-twelve leukemia (STL), non-coding RNA STL 5/6 1 match
v2HS_115231 rab23, member RAS oncogene family RAB23 4/6 4 match
v2HS_117914 transketolase-like 2 TKTL2 2/6 1 match
v2HS_117239 chromosome 9 open reading frame 58 C9orf58 3/6 1 match
v2HS_120429 six-twelve leukemia (STL), non-coding RNA STL 1/6 1 match
v2HS_119206 lon peptidase 2, peroxisomal LONP2 2/6 1 pool 146
58 v2HS_116174 YTH domain containing 2 YTHDC2 1/4 2 match
v2HS_118722 layilin LAYN 2/4 2 match
v2HS_112838 ectonucleoside triphosphate diphosphohydrolase 3 ENTPD3 3/7 4 match
v2HS_112982 chromodomain helicase DNA binding protein 3 CHD3 1/7 3 match
v2HS_116174 YTH domain containing 2 YTHDC2 1/7 2 match
v2HS_112838 ectonucleoside triphosphate diphosphohydrolase 3 ENTPD3 1/12 4 match
v2HS_118254 WD repeat and FYVE domain containing 2 WDFY2 1/12 1 match
v2HS_122548 similar to ribosomal protein S3A RPS3A 4/12 1 pool 53
v2HS_120982 coiled coil domain containing 129 CCDC129 5/12 2 match
59 v2HS_111554 interleukin 2 IL2 8/10 2 match
v2HS_115544 DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 DDX47 2/10 4 match
v2HS_116377 transmemembrane protein 135 TMEM135 1/9 2 match
v2HS_117064 CD1E molecule CD1E 3/9 1 match
v2HS_119967 LOC155004 LOC155004 4/9 2 pool 52
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v2HS_120757 olfactory receptor, family 8, subfamily K, member 1 OR8K1 1/9 2 match
v2HS_108647 LOC349868 LOC349868 1/8 1 pool 79
v2HS_115544 DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 DDX47 3/8 4 match
v2HS_116833 intermediate filament protein syncoilin SYNC 1/8 2 match
60 v2HS_121585 dual specificity phosphatase 3 DUSP3 10/11 1 match
v2HS_117903 glutamine rich 2 QRICH2 4/11 1 match
v2HS_119967 LOC155004 LOC155004 1/11 2 pool 52
v2HS_121585 dual specificity phosphatase 3 DUSP3 2/11 1 match
v2HS_128131 LOC351061 LOC351061 2/11 1 match
v2HS_98079 solute carrier family 22 member 3 SLC22A3 1/11 2 pool 79
v2HS_119967 LOC155004 LOC155004 8/10 2 pool 52
v2HS_121585 dual specificity phosphatase 3 DUSP3 2/10 1 match
64 v2HS_119967 LOC155004 LOC155004 10/11 2 pool 52
v2HS_121013 protease serine 54 PRSS54 3/12 1 match
66 v2HS_117675 latent transforming growth factor b binding protein 2/3 LTBP2/3 15/15
v2HS_118530 RNA exonuclease 1 homolog like 1 REXO1L1 5/13 3 match
v2HS_117675 latent transforming growth factor b binding protein 2/3 LTBP2/3 8/13
v2HS_118530 REX1, RNA exonuclease 1 homolog-like 2 REXO1L1 1/11 3 match
71 v2HS_103818 LOC284804 LOC284804 2/16 1 pool 78
v2HS_119967 LOC155004 LOC155004 9/16 2 pool 52
v2HS_97981 LOC51152 LOC51152 5/16 2 pool 79
72 v2HS_119967 LOC155004 LOC155004 9/10 2 pool 52
74 v2HS_119967 LOC155004 LOC155004 11/12 2 pool 52
77 v2HS_119967 LOC155004 LOC155004 12/12 2 pool 52
78 v2HS_94763 paired related homeobox 1 PRRX1 1/8 1 match
v2HS_99138 solute carrier family 25 SLC25A21 7/8 2 match
v2HS_102207 transmembrane protein 63B TMEM63B 1/12 1 match
v2HS_103818 LOC284804 LOC284804 4/12 1 match
V2HS_95356 armadillo repeat containing, X-linked 2 ARMCX2 2/12 2 match
v2HS_98650 mitochondrial ribosomal protein 63 MRP63 1/12 1 match
v2HS_102155 similar to hypothetical protein KIAA0286 (HA6800) KIAA0286 1/8 1 match
v2HS_108506 LOC349839 LOC349839 1/8 2 match
v2HS_96236 zinc finger and BTB domain containing 1 ZBTB1 2/8 1 match
v2HS_184999 eukaryotic initiation factor 4A isoform 1 EIF4A1 3/10
v2HS_96236 zinc finger and BTB domain containing 1 ZBTB1 1/10 1 match
79 v2HS_105974 LOC345597 LOC345597 3/11 1 match
v2HS_184999 eukaryotic initiation factor 4A isoform 1 EIF4A1 3/11
v2HS_98079 solute carrier family 22, member 3 SLC22A3 4/11 2 match
v2HS_108647 LOC349868 LOC349868 2/7 1 match
v2HS_98079 solute carrier family 22, member 3 SLC22A3 5/7 2 match
v2HS_101943 anthrax toxin receptor-like ANTXRL 1/11 3 match
v2HS_105093 human solute carrier family 35, member F4 SLC35F4 2/11 1 match
v2HS_106472 LOC345713 LOC345713 1/11 1 match
v2HS_107395 LOC346589 LOC346589 1/11 1 match
v2HS_91777 nuclear receptor co-repressor N-Cor 1 NCOR1 4/11 2 match
Non-protein coding RNA 282 NCRNA00282 1/11
80 v2HS_102441 adenylate cyclase 1 ADCY1 5/11 1 match
v2HS_130882 glutamate receptor, metabotropic 3 GRM3 1/11 3 pool 91
v2HS_97368 yippee-like 5 YPEL5 2/11 1 match
v2HS_102441 adenylate cyclase 1 ADCY1 5/10 1 match
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82 v2HS_184999 eukaryotic initiation factor 4A isoform 1 EIF4A1 1/11
v2HS_101845 human prickle-like 2 (Drosophila) PRICKLE2 3/11 1 match
v2HS_109096 LOC349975 LOC349975 1/11 1 pool 84
v2HS_99423 coiled coil domain containing 70 CCDC70 1/11 1 match
v2HS_109596 1/14
v2HS_108399 LOC349811 LOC349811 3/14 1 match
v2HS_184999 eukaryotic initiation factor 4A isoform 1 EIF4A1 1/14
v2HS_93536 proteolipid protein 1 PLP1 5/14 1 match
v2HS_97017 sterile alpha motif domain containing 4A SAMD4A 1/14
v2HS_106158 LOC345672 LOC345672 3/14 2 match
v2HS_93615 p53 TP53 3/14 1 match
v2HS_95112 RAS p21 protein activator 4 RASA4 1/14 1 match
v2HS_99525 BCL2 like 12 BCL2L12 1/14 2 match
v2HS_97017 sterile alpha motif domain containing 4A SAMD4A 4/14
v2HS_94640 aryl hydrocarbon receptor nuclear translocator-like ARNTL 3/10 2 match
v2HS_100174 desmoglein 4 DSG4 2/10 2 pool 145
v2HS_96026 adnp homeobox 2 ADNP2 3/10 1 match
v2HS_100819 Rho GTPase activating protein 20 ARHGAP20 2/10 1 match
84 v2HS_106409 LOC345700 LOC345700 1/11 1 match
v2HS_95019 zinc finger protein 16 ZNF16 9/11 1 match
v2HS_97152 ubiquitin-conjugating enzyme E2, J1 UBE2J1 1/11 1 match
v2HS_95019 zinc finger protein 16 ZNF16 10/11 1 match
94 v2HS_141495 zinc finger protein 454 ZNF454 7/12 2 pool 96
95 v2HS_130457 radial spoke head 10 homolog B (Chlamydomonas) RSPH10B 6/7 3 match
v2HS_131154 potassium inwardly-rectifying channel, subfamily J KCNJ2 1/7 3 match
v2HS_184999 eukaryotic initiation factor 4A isoform 1 EIF4A1 1/3
96 chromosome 9 open reading frame 123 C9orf123 5/13
98 v2HS_141367 cDNA FLJ37626/LOC285500 FLJ37626 10/10 2 match
v2HS_119967 LOC155004 LOC155004 2/11 2 pool 52
v2HS_133299 insulin-like growth factor binding protein 6 IGFBP6 3/11 2 match
v2HS_135564 chromosome X open reading frame 57 CXORF57 5/11 1 match
For each candidate the DNA pool from which it was isolated, the insert reference, target gene, frequency of isolation, as well as the number of shRNAmir
constructs for that gene within the SM2 library are indicated. The last column shows if the recovered insert was a match to a hair pin in that particular pool
("match”) or if it was from another pool ("pool X”).
Table 2 Microarray expression profiling data for common genes
Probe Symbol GA p-value HS p-value pRS_p53 p-value pRS_p21 p-value E7 p-value E2F_DB p-value
208832_at ATXN10 0.36 1E-03 0.25 3E-02 -0.18 2E-01 -0.35 2E-03 0.02 9E-01 -0.23 4E-02
228080_at LAYN 1.04 2E-04 0.30 3E-01 -0.95 1E-03 -0.70 2E-02 -0.56 6E-02 -0.11 8E-01
219922_s_at LTBP2/3 1.32 9E-08 0.66 5E-03 -1.04 2E-05 -1.32 3E-07 -1.19 1E-06 -1.41 4E-08
223690_at LTBP2/3 0.75 5E-09 -0.14 3E-01 -0.52 1E-05 -0.91 2E-10 -1.27 1E-14 -1.22 3E-14
204682_at LTBP2/3 0.57 8E-04 -0.48 8E-03 -0.39 4E-02 -0.94 1E-06 -1.62 3E-12 -2.02 4E-15
227308_x_at LTBP2/3 0.46 5E-05 0.03 9E-01 -0.43 3E-04 -0.57 4E-06 -0.28 2E-02 -0.55 4E-06
218065_s_at TMEM9B 0.44 1E-07 -0.11 2E-01 -0.33 6E-05 -0.38 9E-06 -0.20 1E-02 -0.18 2E-02
222507_s_at TMEM9B 0.39 2E-04 -0.19 1E-01 -0.28 1E-02 -0.34 2E-03 -0.12 3E-01 -0.07 6E-01
Log2 fold changes in gene expression in CL3
EcoR cells upon senescence arrest are indicated as GA and upon shift up of control temperature insensitive HMF3S
cells, from 34°C to 38°C, as HS respectively. Also indicated are the data obtained for these genes from CL3
EcoR cells in which senescence had been bypassed by
silencing of p53 (pRS_p53) or p21
CIP1 (pRS_p21) or by inactivation of pRB using HPV16 E7 (E7) or by expression of the dominant negative E2F-DB protein.
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Page 8 of 12(v2LHS_247318, 58957, 58958 and 58959; Thermo
Scientific Open Biosystems) targetting TMEM9B were
obtained, pooled and introduced into CL3
EcoR cells after
packaging as lentiviruses. The GIPZ lentiviral library
contains the same hair pins as the retroviral library but
is more stable and the constructs are packaged as lenti-
viruses rather than retroviruses. Lentiviral human GIPZ
Lamin A/C shRNAmir (v2LHS_62719) was used as a
negative control. Silencing of TMEM9B was clearly able
to bypass senescence (Figure 4a). Moreover each of the
constructs was individually able to overcome senescence
arrest with v2LHS_58957 being the most efficient [16].
To determine if ATXN10, LAYN and LTBP2/3 were
also able to directly bypass senescence, lentivirus con-
structs from the GIPZ lentiviral shRNAmir library
were used. The complementation assay for LTBP2/3,
in Figure 4b, showed that silencing LTBP2/3 with the
one available silencing construct (v2LHS_34089)
clearly yielded healthy growing colonies. Silencing of
ATXN10 was tested using 4 different silencing con-
structs v2LHS_71735, 71736, 71737 and 71740. All
four constructs were able to overcome senescence and
yielded more growing colonies than the Lamin A/C
negative control (Figure 4c). Silencing of LAYN was
Figure 4 Silencing targets identified from the primary screen.C L 3
EcoR cells were infected in triplicate with lentiviruses prepared from the
indicated GIPZ shRNAmir constructs targetting TMEM9B (a), LTBP2/3 (b), ATXN10 (c) and LAYN (d). Cells resistant to 6 μg/ml puromycin were
isolated, reseeded and assayed for bypass of senescence by culturing at 38°C for 3 weeks. Lentiviruses prepared from the GIPZ shRNAmir Lamin
A/C (v2LHS_62719) construct were used as the negative control. For TMEM9B, the mix of constructs comprised v2LHS_247318, 58957, 58958 and
58959.
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Page 9 of 12tested using 2 different silencing constructs
v2LHS_265009 and 118722; both constructs were able
to bypass growth arrest and produced growing colo-
nies (Figure 4d).
Taken together our results showed that silencing of
TMEM9B, ATXN10, LAYN and LTBP2/3 was able to
bypass senescence in the conditionally immortal human
fibroblasts.
Discussion
To directly identify the downstream effectors of the
p53-p21 and p16-pRB pathways crucial for mediating
entry into senescence, we carried out a loss-of-function
RNA interference screen in the conditionally immortal
HMF3A human fibroblasts. This identified 112 known
genes including p53 and another 29 shRNAmirs target-
ting unidentified loci. Comparison of these known tar-
gets with genes up-regulated upon senescence in these
cells identified 4 common genes TMEM9B, ATXN10,
LAYN and LTBP2/3. Direct silencing of these common
genes using lentiviral shRNAmirs bypasses senescence
in the HMF3A cells. Although none of these genes has
previously been linked to cellular senescence, TMEM9B
has been suggested to be an upstream activator of NF-
B signalling which we have found to have a causal role
in promoting senescence.
The 112 known targets identified by the shRNA
screen comprise a wide variety of genes but most
importantly one of them was the only p53 shRNAmir
(v2HS_93615 from pool 82) present within this library,
thereby internally validating the screen. Moreover all of
the primary targets were identified from single shRNA-
mirs even though we have subsequently shown that
other shRNAmirs corresponding to these targets present
within the library are able to bypass senescence. It is
not clear why other shRNAmirs were not isolated in the
screen; however this is exactly what has been observed
previously by others such as Westbrook and colleagues
[20]. Nevertheless it remains to be demonstrated which
of the targets identified by the primary screen are able
to bypass senescence when assayed individually.
TMEM9B was one of the 4 genes in common between
the shRNA screen and genes known to be up-regulated
upon senescence in HMF3A cells [16]. Moreover
expression of TMEM9B was down-regulated when
senescence was bypassed upon abrogation of the p53-
p21 or p16-pRB pathways. TMEM9B is a glycosylated
protein that localises to lysosome membranes and par-
tially to early endosomes. It has been shown to be a
component of TNF signalling and a module shared
between the interleukin-1 and Toll-like receptor path-
ways. It is also essential for TNF activation of both NF-
B and MAPK pathways by acting downstream of RIP1
and upstream of the MAPK and IB kinases at the level
of the TAK1 complex [19]. TMEM9B was also identified
in a large scale study to identify genes activating NF-B
and MAPK signalling pathways [18]. These results are
all consistent with our finding that in the conditionally
immortal HMF3A cells, senescence growth arrest is
associated with an activation of NF-B signalling and
suppression of this pathway bypasses senescence [16].
The latent TGFb-binding protein 2/3 (LTBP2/3) hair
pin sequence was identified from pool 66. Up-regulation
of LTBP2/3 expression upon growth arrest was reversed
when senescence was overcome. LTBPs are secreted
proteins initially identified through their binding to
TGFb and may be involved in their assembly, secretion
and targetting [21]. LTBP2/3 in particular has been
found to play an essential role in the secretion and tar-
getting of TGFb1 [22]. Since silencing of LTBP2/3 can
bypass senescence in HMF3A cells, it suggests that
LTBP2/3 may be linked with the control of cell growth
and be playing a role in suppressing tumour progression
perhaps through regulation of TGFb.T h i si si na c c o r -
dance with the identification of TGFb as a senescence-
inducing factor in the human lung A549 adenocarci-
noma cells [23]. It is also in accordance with several
other reports suggesting that TGFb1 is capable of indu-
cing cellular senescence. For instance, stimulation of
human diploid fibroblasts with TGFb1 triggers the
appearance of senescence associated-b-galactosidase
activity and increases steady state mRNA levels of senes-
cence associated genes including APO J, fibronectin, and
M22 [24-26]; both APO J (clusterin) and fibronectin are
up-regulated in CL3 cells upon senescence arrest and
this is reversed when senescence is bypassed [16].
Ataxin (ATXN) 10 was slightly up-regulated upon
senescence arrest which was reversed upon silencing of
p53 and p21
CIP1 or ectopic expression of the dominant
negative E2F-DB protein. Spinocerebellar ataxia type 10
(SCA10) is a dominantly inherited disorder character-
ized by ataxia, seizures and anticipation caused by an
intronic ATTCT pentanucleotide repeat expansion. The
product of SCA10 encodes the novel protein, ATXN10,
previously known as E46L, which is widely expressed in
the brain and belongs to the family of armadillo repeat
proteins. Although clinical features of the disease are
well characterized, very little is known about ATXN10.
ATXN10 knock down by RNAi has recently been
shown to cause increased apoptosis in primary cerebel-
lar cultures, implicated in SCA10 pathogenesis [27,28].
This is in contrast to our finding that silencing of
ATXN10 in HMF3A cells by four different shRNAmirs
did not cause apoptosis but promoted growth and per-
mitted a bypass of senescence.
Layilin (LAYN) identified from pool 58 was 2 fold up-
regulated upon senescence arrest, which was reversed
upon abrogation of the growth arrest by inactivation of
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Page 10 of 12either the p53-p21 or the p16-pRB pathways. Moreover
two different LAYN shRNAmirs were found to directly
bypass senescence in HMF3A cells. Layilin is a widely
expressed integral membrane hyaluronan receptor, ori-
ginally identified as a binding partner of talin located in
membrane ruffles. Talin is responsible, along with its
adaptor proteins, for maintaining the cytoskeleton-mem-
brane linkage by binding to integral membrane proteins
and to the cytoskeleton. Recently layilin has been sug-
gested to play a crucial role in lymphatic metastasis of
lung carcinoma A549 cells [29].
In addition to the genes described above, a number of
other interesting genes particularly TAOK1, RAS4A and
ARMCX2 were identified. TAOK1 is a micro-tubule
affinity-regulating kinase required for both chromosome
congression and checkpoint-induced anaphase delay
[30]. It is known to activate the p38MAPK pathway
through the specific phosphorylation of MKK3. This is a
complex pathway responsive to stress stimuli and
involved in cell differentiation and apoptosis and has
been shown to have an important causative role in
senescence [31]. RAS4A encodes a member of the
GAP1 family of GTPase-activating proteins that have
been identified to suppress the Ras/mitogen-activated
protein kinase pathway in response to an elevation of
Ca
2+ ions. Stimuli that increase intracellular Ca
2+ levels
result in the translocation of this protein to the plasma
membrane, where it activates Ras GTPase activity result-
ing in Ras being converted from the active GTP-bound
state to the inactive GDP-bound state and suppression
of downstream signalling [32]. ARMCX2 encodes a
member of the ALEX family of proteins and may play a
role in tumour suppression. This protein contains a
potential N-terminal transmembrane domain and a sin-
gle Armadillo repeat; armadillo repeat containing pro-
teins are involved in development, maintenance of tissue
integrity and suppressing carcinomas [33].
Conclusions
The RNA interference screen has identified 112 known
candidate proteins including p53 and another 29
shRNAmirs targetting as yet unidentified loci. Although
none of them except p53 had previously been linked to
senescence or known to be downstream effectors of the
p53-p21 and p16-pRB tumour suppressor pathways,
directly silencing four of these candidates, TMEM9B,
ATXN10, LAYN and LTBP2/3 bypassed senescence in
CL3
EcoR cells. It remains to be determined whether
direct silencing of any of the other primary candidates
will also bypass senescence. Any genes that can bypass
senescence upon silencing are novel starting points for
identifying the signalling networks that act downstream
of p53 and pRB to induce cellular senescence. The
genes/proteins identified in the screen are also potential
tumour suppressors, and a mechanistic dissection of
their mode of action and role in cancer will undoubtedly
provide new avenues for further research.
Methods
Cell Culture
CL3
EcoR cells were maintained at 34°C ± 0.5°C [15].
Temperature shift experiments were performed at 38°C
± 0.5°C. Phoenix ecotropic and HEK293T cells were
obtained from the ATCC and maintained at 37°C. Cells
w e r eg r o w ni nD u l b e c c o ’s modified Eagles medium
(DMEM) supplemented with 10% (v/v) heat inactivated
foetal bovine serum, 2 mM glutamine, 100 units/ml
penicillin and 100 μg/ml streptomycin. All media and
components were obtained from Invitrogen.
Viral packaging and infection
Lentiviruses were prepared according to Besnier et al.
[34]. Ecotropic viruses were prepared by transfecting
10 μg of retroviral plasmid DNA into phoenix ecotro-
pic cells by FuGENE 6 Transfection reagent (Roche),
according to the manufacturer’si n s t r u c t i o n s .2 4h r s
post-transfection, media was changed and fresh med-
ium added. 48 hrs post-transfection, retroviral super-
natant was harvested, filtered through a 0.45 μm filter
and either used immediately or frozen at -80°C. A sec-
ond harvest was prepared by adding fresh media to
the plates and harvesting the virus supernatant the
next day.
Cells were infected with virus supernatants for 24 hrs
at 34°C. Four days post-infection, antibiotic selection
was added (2 μg/ml puromycin for pRS and pSM2 ret-
roviruses or 6 μg/ml puromycin for pGIPZ shRNAmir
lentiviruses; Invitrogen). Selection of cells infected with
human GIPZ lentiviral shRNAmir constructs in puro-
mycin at 6 μg/ml, enriches for cells with higher levels of
shRNAmir expression. For the senescence bypass assay,
the stably transduced cells were plated at 5 × 10
4 cells
in T-75 flasks or at 1.6 × 10
4 cells in T-25 flasks and
incubated overnight at 34°C. Next day the medium was
changed and the cells shifted to 38°C for 3 weeks. Flasks
which contained more densely growing or bigger colo-
nies were trypsinised, replated and used for extracting
genomic DNA when confluent.
Additional material
Additional file 1: Volume of virus supernatants used for the screen.
The table shows the volume of virus supernatants used for each of the
pools.
Additional file 2: Primary screen. This table shows the pool number,
the number of cells obtained after puromycin selection, the number of
T-75 and T-25cm2 flasks reseeded and the number of growing colonies
observed after 3 weeks at 38°C. Numbers indicated in red correspond to
flasks that were reseeded for extracting genomic DNA.
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Page 11 of 12Additional file 3: Unidentified inserts. This table shows the hair pin
sequences that were not 100% homologous to a gene by BLASTN
analysis of the NCBI human genome data base (http://blast.ncbi.nlm.nih.
gov/Blast.cgi) or could not be linked back to a hair pin sequence within
the Open Biosystems SM2 library; the number of times the insert was
isolated is also indicated.
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